162 related articles for article (PubMed ID: 27510332)
1. Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer.
Sun Z; Adam MA; Kim J; Czito B; Mantyh C; Migaly J
J Gastrointest Surg; 2017 Jan; 21(1):106-111. PubMed ID: 27510332
[TBL] [Abstract][Full Text] [Related]
2. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
[TBL] [Abstract][Full Text] [Related]
4. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
[TBL] [Abstract][Full Text] [Related]
5. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
6. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
7. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparative study of 3 different postoperative radiotherapy techniques (3D-CRT, IMRT, and RapidArc) for II-III stage rectal cancer.
Liu M; Liu B; Wang H; Ding L; Shi Y; Ge C; Su X; Liu X; Dong L
Medicine (Baltimore); 2015 Jan; 94(1):e372. PubMed ID: 25569661
[TBL] [Abstract][Full Text] [Related]
9. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer.
Dapper H; Rodríguez I; Münch S; Peeken JC; Borm K; Combs SE; Habermehl D
Radiat Oncol; 2018 Dec; 13(1):237. PubMed ID: 30509284
[TBL] [Abstract][Full Text] [Related]
10. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
[TBL] [Abstract][Full Text] [Related]
11. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
12. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
[TBL] [Abstract][Full Text] [Related]
13. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
[TBL] [Abstract][Full Text] [Related]
14. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
[TBL] [Abstract][Full Text] [Related]
16. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G; Gupta G; Malviya A; Saroj D
J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
19. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.
Zhu J; Liu F; Gu W; Lian P; Sheng W; Xu J; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2014 Mar; 9():70. PubMed ID: 24606870
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
